RealClearHealth Morning Scan -- 02/01/2016

X
Story Stream
recent articles

Today's Top Stories

U.K. Approves Editing Genes in Human Embryos
Andrew Joseph, Stat
The lead researcher, Kathy Niakan of the Francis Crick Institute, has proposed using the powerful gene editing technology CRISPR-Cas9 to alter the genomes of human embryos to better understand the first days of development after fertilization.

Lawmakers Examine Oversight Of Medical Devices
Chad Terhune, KHN
Members of Congress, federal officials and health-policy experts agree that the Food and Drug Administration’s surveillance system for devices is inadequate and relies too heavily on manufacturers to report problems with their own products.

Low Participation Hampers Cancer Clinical Trials
David Templeton, PPG
Nowadays, most adults with cancer are hesitant to join clinical trials with only 3 to 5 percent of cancer patients volunteering to participate. As a result, one in five cancer studies fails to draw enough participants to determine whether or not the new treatment works, states a Fred Hutchinson Cancer Research Center and the University of Washington study published in December.

* * *

Blue Cross and Blue Shield companies are leading the way to better healthcare, community by community, with high-quality care that puts patients first. Learn more.

* * *

Biogen VP: Google Wants to Take Over CMS
Meghana Keshavan, MedCity
Through Biogen’s discussions and data sharing with Google, Koppel came to the following conclusions: The Silicon Valley giant recognizes that “current payers, using actuarial math – it’s like the 19th century,” he said. Google’s found it can pool big data, and figure out real-life outcomes in actual people.

U.S. Weighs Changes to Blood Donations Due to Zika
D. Thompson, HD
At a media briefing Thursday, Dr. Anthony Fauci, head of the U.S. National Institute of Allergy and Infectious Diseases, said a review of blood donation policies was underway, based on whether a person may have been exposed to the virus that has been linked to thousands of birth defects in Brazil.

Zika Virus Sparks Renewed Debate about Abortion
Jasmine Garsd, NPR
In the 1960s, abortion was illegal in the United States. But an outbreak of rubella (commonly known as German measles or three-day measles) brought the issue of abortion up for public debate. As a result of the national conversations, more Americans came to empathize with those mothers who had an illicit abortion. That was nearly a decade before Roe v. Wade ushered in the era of legal abortions.

Senate Panel to Hold Hearing on Zika Virus
Jordain Carney, The Hill
"Senator [Patty] Murray and I will very soon hold a hearing to gain a better understanding of how the Congress can support efforts to prevent further spread of the virus and protect families from being affected," Sen. Lamar Alexander (R-Tenn.), who chairs the panel, said in a statement.

Trump on Heath Care: 'We'll Work Something Out'
Elize Foley, HuffPo
Republican front-runner Donald Trump is going to "work something out" on health care after he dismantles Obamacare, he said Sunday. He didn't say what exactly that "something" will be -- but the real estate mogul said he's going to have it under control.

An Uncomfortable Question for Cruz on ACA
Matt Fiegenheimer, NYT
Senator Ted Cruz is often asked about doing away with President Obama’s health care law. He is rarely pressed by voters on what will replace it.

Annual Physical Wastes Money, Some Doctors Say
Kim Painter, USAT
A debate over the value of such appointments has been gaining steam among physicians, with views pro and con appearing in major medical journals and in the popular press in recent months.

* * *

Blue Cross and Blue Shield companies understand Americans want healthcare that helps them get healthy faster and stay healthy longer. Community by community, nationwide, we are leading the way to better healthcare through innovative programs that provide high-quality care focused on prevention and wellness. Learn more.

* * *

Not a subscriber? Sign up here.

Comment
Show commentsHide Comments